These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1003406)

  • 1. Use of cluster analysis in the development of structure-activity relations for antitumor triazenes.
    Dunn WJ; Greenberg MJ; Callejas SS
    J Med Chem; 1976 Nov; 19(11):1299-301. PubMed ID: 1003406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice.
    Hansch C; Hatheway GJ; Quinn FR; Greenberg N
    J Med Chem; 1978 Jun; 21(6):574-7. PubMed ID: 671454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.
    Wilman DE; Cox PJ; Goddard PM; Hart LI; Merai K; Newell DR
    J Med Chem; 1984 Jul; 27(7):870-4. PubMed ID: 6737430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, physicochemical properties, and antitumor activities of analogs of 1-phenyl-3-benzyl-3-methyltriazenes.
    Dunn WJ; Greenberg MJ
    J Pharm Sci; 1977 Oct; 66(10):1416-9. PubMed ID: 21950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.
    Lin YT; Loo TL
    J Med Chem; 1972 Feb; 15(2):201-3. PubMed ID: 5008242
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
    Wilman DE; Goddard PM
    J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives.
    Giraldi T; Nisi C; Connors TA; Goddard PM
    J Med Chem; 1977 Jun; 20(6):850-3. PubMed ID: 874961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of haloacetylcarbazole derivatives.
    Kanzawa F; Hoshi A; Omine M; Kuretani K
    Gan; 1973 Aug; 64(4):391-6. PubMed ID: 4752374
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of structural modification on antitumor activity of haloacetylphenothiazines.
    Kanzawa F; Hoshi A; Kuretani K
    Gan; 1972 Jun; 63(3):375-8. PubMed ID: 5072836
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and antitumor activity of alkyltriazenopyrazoles.
    Zakharieva RD; Spassova MK; Karaivanova MC; Golovinsky EV
    Arzneimittelforschung; 1984; 34(6):661-3. PubMed ID: 6541485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of triazenoazaindoles: a new class of triazenes with antitumor activity.
    Diana P; Stagno A; Barraja P; Carbone A; Parrino B; Dall'Acqua F; Vedaldi D; Salvador A; Brun P; Castagliuolo I; Issinger OG; Cirrincione G
    ChemMedChem; 2011 Jul; 6(7):1291-9. PubMed ID: 21523910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and antitumour activity of 8-triazenopurines].
    Zhang WN
    Yao Xue Xue Bao; 1982 Dec; 17(12):909-16. PubMed ID: 7183123
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties.
    Vaughan K; Tang Y; Llanos G; Horton JK; Simmonds RJ; Hickman JA; Stevens MF
    J Med Chem; 1984 Mar; 27(3):357-63. PubMed ID: 6699881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents.
    Smith RH; Scudiero DA; Michejda CJ
    J Med Chem; 1990 Sep; 33(9):2579-83. PubMed ID: 2391696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of antitumor activity of 1-[N, N-bis(2-chloroethyl) sulfamoylphenyl]-3,3-dialkyltriazenes.
    Lalezari I; Afghahi F
    J Pharm Sci; 1975 Apr; 64(4):698-9. PubMed ID: 1142087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ; Loo TL
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional-group modifications of dextran for linkage to a diazonium group. A potential vehicle for tumour targeting of antineoplastic triazenes.
    Baki AV; Vaughan K
    Carbohydr Res; 1982 Jul; 105(1):57-68. PubMed ID: 6180830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.